{
    "title": "FDA approves Genentech drug for advanced lung cancer",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3356567/FDA-approves-Genentech-drug-advanced-lung-cancer.html",
    "date": "2015-12-11",
    "keywords": [
        "drug",
        "lung",
        "cancer",
        "approval",
        "effect",
        "percent",
        "genentech",
        "alk",
        "brain",
        "fda",
        "gmt",
        "december",
        "cell",
        "mutation",
        "drugmaker",
        "study",
        "benefit",
        "average",
        "group",
        "muscle",
        "press",
        "email",
        "food",
        "administration",
        "type",
        "optionsalecensa",
        "nonsmall",
        "gene",
        "treatment",
        "pfizer",
        "lymphoma",
        "kinase",
        "growth",
        "medicine",
        "condition",
        "headtohead",
        "midstage",
        "patient",
        "twiceaday",
        "pill",
        "xalkori",
        "alecensa",
        "alectinib",
        "addition",
        "evidence",
        "dr",
        "richard",
        "pazdur",
        "director",
        "office",
        "hematology",
        "oncology",
        "statementalecensa",
        "unit",
        "roche",
        "price",
        "month",
        "company",
        "assistance",
        "copay",
        "insurance",
        "copaymentlung",
        "cause",
        "institute",
        "year",
        "stage",
        "mutationalecensa",
        "inflammation",
        "side",
        "constipation",
        "pain",
        "swelling",
        "review",
        "breakthrough",
        "linda",
        "johnson",
        "httpstwittercomlindaj_onpharma"
    ],
    "category": [
        "wires",
        "ap"
    ]
}